These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2085799

  • 1. Inactivation of rat liver microsomal steroid hydroxylations by 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine: evidence for selectivity among steroid-inducible cytochrome P450IIIA forms.
    Riddick DS, McGilvray I, Marks GS.
    Can J Physiol Pharmacol; 1990 Dec; 68(12):1533-41. PubMed ID: 2085799
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on hepatic cytochrome P-450 heme, apoproteins, and catalytic activities following in vivo administration to rats.
    Riddick DS, Park SS, Gelboin HV, Marks GS.
    Mol Pharmacol; 1990 Jan; 37(1):130-6. PubMed ID: 2405248
    [Abstract] [Full Text] [Related]

  • 5. Inactivation of chick embryo hepatic cytochrome P450 1A, 2H and 3A following in ovo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine and 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone.
    McNamee JP, Kimmett SM, Marks GS.
    Biochem Pharmacol; 1995 May 17; 49(10):1443-52. PubMed ID: 7763287
    [Abstract] [Full Text] [Related]

  • 6. Chick embryo liver microsomal steroid hydroxylations: induction by dexamethasone, phenobarbital, and glutethimide and inactivation following the in ovo administration of porphyrinogenic compounds.
    Kimmett SM, McNamee JP, Marks GS.
    Can J Physiol Pharmacol; 1996 Jan 17; 74(1):97-103. PubMed ID: 8963959
    [Abstract] [Full Text] [Related]

  • 7. Mechanism-based inactivation of hepatic cytochrome P450 2C6 and P450 3A1 following in vivo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine to rats: differences from previously observed in vitro results.
    Kimmett SM, McNamee JP, Marks GS.
    Can J Physiol Pharmacol; 1994 Apr 17; 72(4):397-401. PubMed ID: 7922872
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
    Stevens JC, Halpert J.
    Mol Pharmacol; 1988 Jan 17; 33(1):103-10. PubMed ID: 3336347
    [Abstract] [Full Text] [Related]

  • 11. Ferrochelatase-inhibitory activity and N-alkylprotoporphyrin formation with analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine (DDC) containing extended 4-alkyl groups: implications for the active site of ferrochelatase.
    McCluskey SA, Marks GS, Sutherland EP, Jacobsen N, Ortiz de Montellano PR.
    Mol Pharmacol; 1986 Oct 17; 30(4):352-7. PubMed ID: 3762522
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
    Marks GS, Allen DT, Johnston CT, Sutherland EP, Nakatsu K, Whitney RA.
    Mol Pharmacol; 1985 Apr 17; 27(4):459-65. PubMed ID: 3982391
    [Abstract] [Full Text] [Related]

  • 14. Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities.
    Wortelboer HM, de Kruif CA, van Iersel AA, Falke HE, Noordhoek J, Blaauboer BJ.
    Biochem Pharmacol; 1991 Jul 05; 42(2):381-90. PubMed ID: 1859452
    [Abstract] [Full Text] [Related]

  • 15. Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adducts.
    Correia MA, Decker C, Sugiyama K, Caldera P, Bornheim L, Wrighton SA, Rettie AE, Trager WF.
    Arch Biochem Biophys; 1987 Nov 01; 258(2):436-51. PubMed ID: 3674884
    [Abstract] [Full Text] [Related]

  • 16. The biochemical basis for the species difference in hepatic microsomal 4-vinylcyclohexene epoxidation between female mice and rats.
    Smith BJ, Sipes IG, Stevens JC, Halpert JR.
    Carcinogenesis; 1990 Nov 01; 11(11):1951-7. PubMed ID: 2225327
    [Abstract] [Full Text] [Related]

  • 17. Increased expression of cytochrome P450 IIIA2 in male rat liver after dietary vitamin A supplementation.
    Murray M, Cantrill E, Martini R, Farrell GC.
    Arch Biochem Biophys; 1991 May 01; 286(2):618-24. PubMed ID: 1897981
    [Abstract] [Full Text] [Related]

  • 18. Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver.
    Craig PI, Mehta I, Murray M, McDonald D, Aström A, van der Meide PH, Farrell GC.
    Mol Pharmacol; 1990 Sep 01; 38(3):313-8. PubMed ID: 1698250
    [Abstract] [Full Text] [Related]

  • 19. Specifically designed thiosteroids as active-site-directed probes for functional dissection of rat liver cytochrome P450 3A isozymes.
    Underwood MC, Cashman JR, Correia MA.
    Chem Res Toxicol; 1992 Sep 01; 5(1):42-53. PubMed ID: 1581535
    [Abstract] [Full Text] [Related]

  • 20. Microsomal cytochrome P450-dependent steroid metabolism in male sheep liver. Quantitative importance of 6 beta-hydroxylation and evidence for the involvement of a P450 from the IIIA subfamily in the pathway.
    Murray M.
    J Steroid Biochem Mol Biol; 1991 May 01; 38(5):611-9. PubMed ID: 2039754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.